Eisai
4523.T
#2662
Rank
NZ$11.39 B
Marketcap
NZ$40.39
Share price
1.53%
Change (1 day)
-13.41%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): NZ$1.42

According to Eisai's latest financial reports the company's current EPS (TTM) is NZ$1.48. an increase over its 2024 EPS that were of NZ$1.67.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025NZ$1.8711.85%
2024NZ$1.67-32.63%
2023NZ$2.485.52%
2022NZ$2.35-74.01%
2021NZ$9.05-66.58%
2020NZ$27.0998.24%
2019NZ$13.6617.01%
2018NZ$11.6837.78%
2017NZ$8.48-27.62%
2016NZ$11.7135.33%
2015NZ$8.65-2.82%
2014NZ$8.90-27.66%
2013NZ$12.31-27.49%
2012NZ$16.98-12.67%
2011NZ$19.4488.08%
2010NZ$10.34-11.06%
2009NZ$11.62-390.15%
2008NZ-$4.01-127.78%
2007NZ$14.4211.78%
2006NZ$12.904.38%
2005NZ$12.367.4%
2004NZ$11.5143.03%
2003NZ$8.0525.09%
2002NZ$6.4352.67%
2001NZ$4.2169.76%
2000NZ$2.48